Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded
- Contract number
- SPE2DB25FYPNN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,019
Award facts
- Contract value 100% obligated
- $13,018.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,018.54 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, an auto-injector pharmaceutical product. This firm fixed-price contract, awarded on August 29, 2025, with an ultimate completion date of September 2, 2025, represents a non-competitive set-aside delivery order. The contract specifies Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's corporate headquarters location. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical medical procurement needs for military and veteran healthcare systems through its federal contract portfolio. The company's DLA Troop Support Medical contract encompasses a wide spectrum of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This specific delivery order for HUMIRA, a immunosuppressant therapy used to treat autoimmune conditions, exemplifies the company's role in supporting Defense Health Agency and other federal healthcare systems with essential pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DB25FYPNN?
SPE2DB25FYPNN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 29, 2025.
How much is contract SPE2DB25FYPNN worth?
The government has obligated $13,019 on SPE2DB25FYPNN.
Is contract SPE2DB25FYPNN an order under another contract?
Yes. SPE2DB25FYPNN is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FYPNN competed?
The extent of competition for SPE2DB25FYPNN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award